NCR3LG1 and neoplasm: The B7-H6-specific BiTE promoted T cell cytotoxicity and IFN-γ secretion against B7-H6+ tumor cells, which enhanced the survival of lymphoma-bearing mice and decreased the tumor burden of melanoma- and ovarian cancer-bearing mice (190).